GO:0006259 | DNA metabolic process | 15.89% (17/107) | 4.05 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 16.82% (18/107) | 3.1 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 17.76% (19/107) | 2.64 | 0.0 | 0.0 |
GO:0003677 | DNA binding | 12.15% (13/107) | 3.39 | 0.0 | 0.0 |
GO:0044260 | cellular macromolecule metabolic process | 18.69% (20/107) | 2.42 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 17.76% (19/107) | 2.54 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 17.76% (19/107) | 2.52 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 17.76% (19/107) | 2.54 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 17.76% (19/107) | 2.36 | 0.0 | 0.0 |
GO:0006270 | DNA replication initiation | 3.74% (4/107) | 6.85 | 0.0 | 1e-06 |
GO:0051052 | regulation of DNA metabolic process | 2.8% (3/107) | 7.44 | 0.0 | 7e-06 |
GO:0006275 | regulation of DNA replication | 2.8% (3/107) | 7.44 | 0.0 | 7e-06 |
GO:0043170 | macromolecule metabolic process | 18.69% (20/107) | 1.88 | 0.0 | 8e-06 |
GO:0006260 | DNA replication | 4.67% (5/107) | 4.68 | 1e-06 | 2.6e-05 |
GO:0003676 | nucleic acid binding | 13.08% (14/107) | 2.18 | 3e-06 | 4.2e-05 |
GO:0044237 | cellular metabolic process | 19.63% (21/107) | 1.64 | 3e-06 | 4.4e-05 |
GO:0006807 | nitrogen compound metabolic process | 19.63% (21/107) | 1.62 | 3e-06 | 5.1e-05 |
GO:0043229 | intracellular organelle | 7.48% (8/107) | 3.14 | 4e-06 | 5.3e-05 |
GO:0043226 | organelle | 7.48% (8/107) | 3.12 | 4e-06 | 5.3e-05 |
GO:0006974 | cellular response to DNA damage stimulus | 5.61% (6/107) | 3.79 | 5e-06 | 5.6e-05 |
GO:0033554 | cellular response to stress | 5.61% (6/107) | 3.79 | 5e-06 | 5.6e-05 |
GO:0051716 | cellular response to stimulus | 5.61% (6/107) | 3.79 | 5e-06 | 5.6e-05 |
GO:0006950 | response to stress | 5.61% (6/107) | 3.67 | 8e-06 | 8.8e-05 |
GO:0005488 | binding | 29.91% (32/107) | 1.12 | 1.1e-05 | 0.000112 |
GO:0044238 | primary metabolic process | 19.63% (21/107) | 1.5 | 1.3e-05 | 0.000127 |
GO:0005634 | nucleus | 4.67% (5/107) | 3.94 | 1.9e-05 | 0.000174 |
GO:0006269 | DNA replication, synthesis of RNA primer | 1.87% (2/107) | 7.85 | 1.9e-05 | 0.000179 |
GO:0071704 | organic substance metabolic process | 19.63% (21/107) | 1.44 | 2.3e-05 | 0.000209 |
GO:0050896 | response to stimulus | 5.61% (6/107) | 3.37 | 2.6e-05 | 0.000226 |
GO:0016779 | nucleotidyltransferase activity | 4.67% (5/107) | 3.83 | 2.7e-05 | 0.000228 |
GO:0009987 | cellular process | 21.5% (23/107) | 1.33 | 3.1e-05 | 0.000251 |
GO:0005694 | chromosome | 2.8% (3/107) | 5.53 | 3.5e-05 | 0.00027 |
GO:0009059 | macromolecule biosynthetic process | 6.54% (7/107) | 2.93 | 3.9e-05 | 0.000297 |
GO:0003896 | DNA primase activity | 1.87% (2/107) | 7.27 | 5.6e-05 | 0.000409 |
GO:0006281 | DNA repair | 4.67% (5/107) | 3.59 | 6.2e-05 | 0.000443 |
GO:0043227 | membrane-bounded organelle | 4.67% (5/107) | 3.5 | 8.3e-05 | 0.00056 |
GO:0043231 | intracellular membrane-bounded organelle | 4.67% (5/107) | 3.5 | 8.3e-05 | 0.00056 |
GO:1901363 | heterocyclic compound binding | 17.76% (19/107) | 1.36 | 0.000129 | 0.000828 |
GO:0097159 | organic cyclic compound binding | 17.76% (19/107) | 1.36 | 0.000129 | 0.000828 |
GO:0008152 | metabolic process | 20.56% (22/107) | 1.21 | 0.000163 | 0.00102 |
GO:0044424 | intracellular part | 9.35% (10/107) | 2.01 | 0.000198 | 0.001208 |
GO:0140097 | catalytic activity, acting on DNA | 3.74% (4/107) | 3.76 | 0.000219 | 0.001303 |
GO:0003887 | DNA-directed DNA polymerase activity | 2.8% (3/107) | 4.58 | 0.000266 | 0.001546 |
GO:0034061 | DNA polymerase activity | 2.8% (3/107) | 4.53 | 0.000295 | 0.001674 |
GO:0044464 | cell part | 9.35% (10/107) | 1.89 | 0.00038 | 0.002109 |
GO:0000166 | nucleotide binding | 12.15% (13/107) | 1.49 | 0.000701 | 0.00373 |
GO:1901265 | nucleoside phosphate binding | 12.15% (13/107) | 1.49 | 0.000701 | 0.00373 |
GO:0005524 | ATP binding | 10.28% (11/107) | 1.64 | 0.000822 | 0.00428 |
GO:0030554 | adenyl nucleotide binding | 10.28% (11/107) | 1.63 | 0.00089 | 0.004448 |
GO:0032559 | adenyl ribonucleotide binding | 10.28% (11/107) | 1.63 | 0.000872 | 0.00445 |
GO:0008150 | biological_process | 25.23% (27/107) | 0.89 | 0.000975 | 0.004777 |
GO:0036094 | small molecule binding | 12.15% (13/107) | 1.44 | 0.001016 | 0.004887 |
GO:0030983 | mismatched DNA binding | 1.87% (2/107) | 5.27 | 0.001193 | 0.005421 |
GO:0006298 | mismatch repair | 1.87% (2/107) | 5.27 | 0.001193 | 0.005421 |
GO:0034645 | cellular macromolecule biosynthetic process | 4.67% (5/107) | 2.65 | 0.00125 | 0.005582 |
GO:0008144 | drug binding | 10.28% (11/107) | 1.57 | 0.001187 | 0.005601 |
GO:0043168 | anion binding | 11.21% (12/107) | 1.39 | 0.002137 | 0.009375 |
GO:0044249 | cellular biosynthetic process | 7.48% (8/107) | 1.78 | 0.002327 | 0.010031 |
GO:0003674 | molecular_function | 33.64% (36/107) | 0.64 | 0.002676 | 0.010965 |
GO:0035639 | purine ribonucleoside triphosphate binding | 10.28% (11/107) | 1.42 | 0.002673 | 0.011136 |
GO:1901576 | organic substance biosynthetic process | 7.48% (8/107) | 1.75 | 0.002666 | 0.011296 |
GO:0032555 | purine ribonucleotide binding | 10.28% (11/107) | 1.42 | 0.002805 | 0.011312 |
GO:0032299 | ribonuclease H2 complex | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0009265 | 2'-deoxyribonucleotide biosynthetic process | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0045005 | DNA-dependent DNA replication maintenance of fidelity | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0031144 | proteasome localization | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0008156 | negative regulation of DNA replication | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0019692 | deoxyribose phosphate metabolic process | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0034629 | cellular protein-containing complex localization | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0071630 | nuclear protein quality control by the ubiquitin-proteasome system | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0006231 | dTMP biosynthetic process | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:2000104 | negative regulation of DNA-dependent DNA replication | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0090329 | regulation of DNA-dependent DNA replication | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0048478 | replication fork protection | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0006515 | protein quality control for misfolded or incompletely synthesized proteins | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0009162 | deoxyribonucleoside monophosphate metabolic process | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0009177 | pyrimidine deoxyribonucleoside monophosphate biosynthetic process | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0009129 | pyrimidine nucleoside monophosphate metabolic process | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0051053 | negative regulation of DNA metabolic process | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0050797 | thymidylate synthase (FAD) activity | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0046385 | deoxyribose phosphate biosynthetic process | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0046073 | dTMP metabolic process | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0042083 | 5,10-methylenetetrahydrofolate-dependent methyltransferase activity | 0.93% (1/107) | 7.85 | 0.004332 | 0.01152 |
GO:0017076 | purine nucleotide binding | 10.28% (11/107) | 1.41 | 0.00292 | 0.011587 |
GO:0043167 | ion binding | 13.08% (14/107) | 1.13 | 0.004662 | 0.012269 |
GO:0032553 | ribonucleotide binding | 10.28% (11/107) | 1.38 | 0.00339 | 0.013242 |
GO:0097367 | carbohydrate derivative binding | 10.28% (11/107) | 1.38 | 0.00347 | 0.013345 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 1.87% (2/107) | 4.1 | 0.006079 | 0.015832 |
GO:0009058 | biosynthetic process | 7.48% (8/107) | 1.64 | 0.004249 | 0.016096 |
GO:0034062 | 5'-3' RNA polymerase activity | 1.87% (2/107) | 3.94 | 0.007471 | 0.018866 |
GO:0097747 | RNA polymerase activity | 1.87% (2/107) | 3.94 | 0.007471 | 0.018866 |
GO:0051276 | chromosome organization | 1.87% (2/107) | 3.94 | 0.007471 | 0.018866 |
GO:0005515 | protein binding | 12.15% (13/107) | 1.09 | 0.007891 | 0.019726 |
GO:0009262 | deoxyribonucleotide metabolic process | 0.93% (1/107) | 6.85 | 0.008645 | 0.020583 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 0.93% (1/107) | 6.85 | 0.008645 | 0.020583 |
GO:0010498 | proteasomal protein catabolic process | 0.93% (1/107) | 6.85 | 0.008645 | 0.020583 |
GO:0031503 | protein-containing complex localization | 0.93% (1/107) | 6.85 | 0.008645 | 0.020583 |
GO:0044265 | cellular macromolecule catabolic process | 1.87% (2/107) | 3.85 | 0.008471 | 0.020967 |
GO:0003690 | double-stranded DNA binding | 1.87% (2/107) | 3.72 | 0.010076 | 0.023765 |
GO:0006310 | DNA recombination | 1.87% (2/107) | 3.64 | 0.011215 | 0.026204 |
GO:0043228 | non-membrane-bounded organelle | 2.8% (3/107) | 2.68 | 0.01161 | 0.02663 |
GO:0043232 | intracellular non-membrane-bounded organelle | 2.8% (3/107) | 2.68 | 0.01161 | 0.02663 |
GO:0009057 | macromolecule catabolic process | 1.87% (2/107) | 3.6 | 0.011805 | 0.026831 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 0.93% (1/107) | 6.27 | 0.012939 | 0.028882 |
GO:0006220 | pyrimidine nucleotide metabolic process | 0.93% (1/107) | 6.27 | 0.012939 | 0.028882 |
GO:0030163 | protein catabolic process | 0.93% (1/107) | 5.85 | 0.017215 | 0.035277 |
GO:0051983 | regulation of chromosome segregation | 0.93% (1/107) | 5.85 | 0.017215 | 0.035277 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 0.93% (1/107) | 5.85 | 0.017215 | 0.035277 |
GO:1905818 | regulation of chromosome separation | 0.93% (1/107) | 5.85 | 0.017215 | 0.035277 |
GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 0.93% (1/107) | 5.85 | 0.017215 | 0.035277 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 0.93% (1/107) | 5.85 | 0.017215 | 0.035277 |
GO:0033047 | regulation of mitotic sister chromatid segregation | 0.93% (1/107) | 5.85 | 0.017215 | 0.035277 |
GO:0033045 | regulation of sister chromatid segregation | 0.93% (1/107) | 5.85 | 0.017215 | 0.035277 |
GO:0010965 | regulation of mitotic sister chromatid separation | 0.93% (1/107) | 5.85 | 0.017215 | 0.035277 |
GO:0006996 | organelle organization | 1.87% (2/107) | 3.36 | 0.016302 | 0.036067 |
GO:0007088 | regulation of mitotic nuclear division | 0.93% (1/107) | 5.53 | 0.021473 | 0.040062 |
GO:0007346 | regulation of mitotic cell cycle | 0.93% (1/107) | 5.53 | 0.021473 | 0.040062 |
GO:1901987 | regulation of cell cycle phase transition | 0.93% (1/107) | 5.53 | 0.021473 | 0.040062 |
GO:0009890 | negative regulation of biosynthetic process | 0.93% (1/107) | 5.53 | 0.021473 | 0.040062 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 0.93% (1/107) | 5.53 | 0.021473 | 0.040062 |
GO:0033044 | regulation of chromosome organization | 0.93% (1/107) | 5.53 | 0.021473 | 0.040062 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 0.93% (1/107) | 5.53 | 0.021473 | 0.040062 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 0.93% (1/107) | 5.53 | 0.021473 | 0.040062 |
GO:0051783 | regulation of nuclear division | 0.93% (1/107) | 5.53 | 0.021473 | 0.040062 |
GO:0031327 | negative regulation of cellular biosynthetic process | 0.93% (1/107) | 5.53 | 0.021473 | 0.040062 |
GO:0006401 | RNA catabolic process | 0.93% (1/107) | 5.53 | 0.021473 | 0.040062 |
GO:0003910 | DNA ligase (ATP) activity | 0.93% (1/107) | 5.53 | 0.021473 | 0.040062 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 0.93% (1/107) | 5.27 | 0.025712 | 0.046581 |
GO:0003909 | DNA ligase activity | 0.93% (1/107) | 5.27 | 0.025712 | 0.046581 |
GO:0005680 | anaphase-promoting complex | 0.93% (1/107) | 5.27 | 0.025712 | 0.046581 |
GO:0000152 | nuclear ubiquitin ligase complex | 0.93% (1/107) | 5.27 | 0.025712 | 0.046581 |